Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Johnson & Johnson
MedTech
J&J gets FDA OK to begin trials for its Ottava surgical robot
Johnson & Johnson MedTech has received a go-ahead from the FDA to begin human clinical trials of its Ottava surgical robot.
Conor Hale
Nov 12, 2024 1:45pm
FDA approves J&J’s Varipulse pulsed field ablation system
Nov 7, 2024 3:00pm
TCT: Abiomed clears pivotal study for shrinkable heart pump
Oct 30, 2024 9:00am
J&J jettisons several programs, including ph. 2 Alzheimer's work
Oct 15, 2024 2:00pm
J&J posts adolescent myasthenia gravis data on $6B FcRn blocker
Oct 15, 2024 9:25am
J&J stops phase 3 bladder cancer trial after interim review flop
Oct 8, 2024 4:58am
